These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29171010)

  • 1. Prenatal exposure to ketamine in rats: Implications on animal models of schizophrenia.
    Coronel-Oliveros CM; Pacheco-Calderón R
    Dev Psychobiol; 2018 Jan; 60(1):30-42. PubMed ID: 29171010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Receptor antagonist of NMDA and animal models of schizophrenia].
    Bian SZ; Zhang J; Liu WL; Sun ZH; Gu ZL; Jiang XG
    Fa Yi Xue Za Zhi; 2009 Dec; 25(6):443-6. PubMed ID: 20225623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice.
    Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S
    Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of developing schizophrenia in animals exposed to cigarette smoke during the gestational period.
    Zugno AI; Oliveira MB; Mastella GA; Heylmann ASA; Canever L; Pacheco FD; Damazio LS; Citadin SA; de Lucca LA; Simões LR; Malgarin F; Budni J; Barichello T; Schuck PF; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():199-206. PubMed ID: 28229913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine administered to pregnant rats in the second trimester causes long-lasting behavioral disorders in offspring.
    Zhao T; Li Y; Wei W; Savage S; Zhou L; Ma D
    Neurobiol Dis; 2014 Aug; 68():145-55. PubMed ID: 24780497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia.
    Zurawek D; Salerno-Kochan A; Dziedzicka-Wasylewska M; Nikiforuk A; Kos T; Popik P
    Schizophr Res; 2018 Feb; 192():423-430. PubMed ID: 28433499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.
    Kittelberger K; Hur EE; Sazegar S; Keshavan V; Kocsis B
    Brain Struct Funct; 2012 Apr; 217(2):395-409. PubMed ID: 21979451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic Ketamine Produces a Downregulation of Prefrontal Cortex NMDA Receptors and Anxiety-Like Behavior in Adult Offspring.
    Ren W; Liu X; Cheng L; Wang G; Liu X; Peng L; Wang Y
    Neuroscience; 2019 Sep; 415():18-30. PubMed ID: 31325561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia.
    Wedzony K; Fijal K; Mackowiak M; Chocyk A; Zajaczkowski W
    Neuroscience; 2008 Jun; 153(4):1370-9. PubMed ID: 18434025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
    Bubeníková-Valesová V; Horácek J; Vrajová M; Höschl C
    Neurosci Biobehav Rev; 2008 Jul; 32(5):1014-23. PubMed ID: 18471877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine modulates theta and gamma oscillations.
    Lazarewicz MT; Ehrlichman RS; Maxwell CR; Gandal MJ; Finkel LH; Siegel SJ
    J Cogn Neurosci; 2010 Jul; 22(7):1452-64. PubMed ID: 19583475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal immune activation induces age-related alterations in rat offspring: Effects upon NMDA receptors and behaviors.
    Hao K; Su X; Luo B; Cai Y; Chen T; Yang Y; Shao M; Song M; Zhang L; Zhong Z; Li W; Lv L
    Behav Brain Res; 2019 Sep; 370():111946. PubMed ID: 31112730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NMDA antagonist model for schizophrenia: promise and pitfalls.
    Abi-Saab WM; D'Souza DC; Moghaddam B; Krystal JH
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():104-9. PubMed ID: 9754841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of esketamine in the treatment of negative symptoms in schizophrenia - A case series.
    Nunes MV; Adelino MPM; Ajub E; Quarantini LC; Lacerda ALT
    Schizophr Res; 2018 Dec; 202():394-396. PubMed ID: 29935883
    [No Abstract]   [Full Text] [Related]  

  • 15. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
    de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.
    Nikiforuk A; Hołuj M; Kos T; Popik P
    Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Analysis of the Effects of Maternal Immune Activation on Rat Cytokines during Pregnancy and Behavior of the Male Offspring Relevant to Schizophrenia.
    Lins BR; Hurtubise JL; Roebuck AJ; Marks WN; Zabder NK; Scott GA; Greba Q; Dawicki W; Zhang X; Rudulier CD; Gordon JR; Howland JG
    eNeuro; 2018; 5(4):. PubMed ID: 30225350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic exposure to cigarette smoke during gestation results in altered cholinesterase enzyme activity and behavioral deficits in adult rat offspring: potential relevance to schizophrenia.
    Zugno AI; Fraga DB; De Luca RD; Ghedim FV; Deroza PF; Cipriano AL; Oliveira MB; Heylmann AS; Budni J; Souza RP; Quevedo J
    J Psychiatr Res; 2013 Jun; 47(6):740-6. PubMed ID: 23472836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired discrimination of a subanesthetic dose of ketamine in a maternal immune activation model of schizophrenia risk.
    Meighan W; Elston TW; Bilkey D; Ward RD
    J Psychopharmacol; 2021 Sep; 35(9):1141-1151. PubMed ID: 34229522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.